Revenio Group Corporation has signed a license agreement with Tide Medical Oy for a patented invention to diagnose  asthma. The agreement allows Revenio to use this invention to develop and commercialize products related to the screening, diagnosis, monitoring and treatment of asthma. It likelywill take several years before the products become commercially significant for the company.

“Our goal is to provide physicians with an accurate, user-friendly and mobile device that will make it considerably easier to screen for, diagnose and monitor asthma in infants and young children.  In the longer term, we aim to expand our product portfolio for the screening, diagnosis and monitoring of asthma to cover adults and those suffering from chronic obstructive pulmonary disease,” says the Revenio Group’s president and CEO Olli-Pekka Salovaara.

Source: Revenio Group Corporation